Etaluma Announces Dr. Mary Harper as VP of Business Development
June 10, 2015 – (Carlsbad, CA) Etaluma announced today that Dr. Mary Harper has joined Etaluma as Vice President of Business Development. Mary was previously a Scientific Adviser for Etaluma. “Mary has provided Etaluma superb scientific and business guidance as Scientific Adviser. We are so fortunate to have Mary as part of the team and focus her talents full-time to further Etaluma’s success!” commented Dr. Chris Shumate, President, CEO and co-Founder of Etaluma. Mary has over 25 years experience leading R&D programs and business development efforts in the biotech industry. Most notably, she has worked to develop and commercialize a range of nucleic acid technologies, including gene regulation and transcription assays, gene therapy, antisense therapeutics and in situ hybridization. She has also worked on protein biologics and the design and sale of laboratory tools. Companies where she has held senior management positions include Gen-Probe, Genta, Introgen Therapeutics, Desmos, Genpathway and V&P Scientific. Her expertise also extends to product development, operations, program management and intellectual property. Education: Ph.D. Molecular Genetics, University of Minnesota.
More information about Etaluma can be found at www.etaluma.com.